Background: Dermatitis Herpetiformis (DH) diagnosis relies on direct immunofluorescence (DIF) on skin biopsy. Serology for anti-epidermal transglutaminase antibodies (Anti-TG3 Abs) has attracted interest, being inexpensive and less invasive. However, the available test has variable sensitivity and low specificity in Coeliac Disease (CD) patients without DH. Objective: To evaluate the diagnostic accuracy and reproducibility of a novel quantitative ELISA for the measurement of Anti-TG3 Abs. Methods: ELISA was set-up with recombinant TG3 and a standard curve based on a human recombinant monoclonal IgA anti-TG3. Sera of 57 DH patients, 212 CD patients, 120 patients with non-gluten related gastrointestinal diseases (CTRL) and 168 healthy controls (HC) were tested. Results: The test was reproducible with high sensitivity (91%). Test specificity was high when considering HC (99%) as well as CTRL (98%). Interestingly in CD patients test specificity was agedependent and was higher (97%) in patients ≤ 25 years of age. Limitations: Not all DH were confirmed by DIF. Conclusion: The ELISA test could be used as a screening tool when DH is clinically suspected and may serve as a sole diagnostic test in younger patients. The quantification of Anti-TG3 Abs levels will facilitate the comparison of results from different laboratories.

A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis

Sblattero, D.;Lega, S.
;
Stefani, C.;Marano, F.;Gaita, B.;De Leo, L.;Berti, I.;Barbi, E.;Bramuzzo, M.;Not, T.
2020-01-01

Abstract

Background: Dermatitis Herpetiformis (DH) diagnosis relies on direct immunofluorescence (DIF) on skin biopsy. Serology for anti-epidermal transglutaminase antibodies (Anti-TG3 Abs) has attracted interest, being inexpensive and less invasive. However, the available test has variable sensitivity and low specificity in Coeliac Disease (CD) patients without DH. Objective: To evaluate the diagnostic accuracy and reproducibility of a novel quantitative ELISA for the measurement of Anti-TG3 Abs. Methods: ELISA was set-up with recombinant TG3 and a standard curve based on a human recombinant monoclonal IgA anti-TG3. Sera of 57 DH patients, 212 CD patients, 120 patients with non-gluten related gastrointestinal diseases (CTRL) and 168 healthy controls (HC) were tested. Results: The test was reproducible with high sensitivity (91%). Test specificity was high when considering HC (99%) as well as CTRL (98%). Interestingly in CD patients test specificity was agedependent and was higher (97%) in patients ≤ 25 years of age. Limitations: Not all DH were confirmed by DIF. Conclusion: The ELISA test could be used as a screening tool when DH is clinically suspected and may serve as a sole diagnostic test in younger patients. The quantification of Anti-TG3 Abs levels will facilitate the comparison of results from different laboratories.
19-lug-2020
Pubblicato
https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16822
File in questo prodotto:
File Dimensione Formato  
JEADV-2020 finale.pdf

Open Access dal 20/06/2021

Descrizione: The final publication is available at link https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16822
Tipologia: Bozza finale post-referaggio (post-print)
Licenza: Copyright Editore
Dimensione 452.78 kB
Formato Adobe PDF
452.78 kB Adobe PDF Visualizza/Apri
jdv.16822.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 272.45 kB
Formato Adobe PDF
272.45 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2969616
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
social impact